首页> 外文期刊>Journal of Kathmandu Medical College >Intralesional Bleomycin injection in head and neck haemangioma and vascular malformation: A nonsurgical treatment
【24h】

Intralesional Bleomycin injection in head and neck haemangioma and vascular malformation: A nonsurgical treatment

机译:头颈部血管瘤和血管畸形内注射博莱霉素的非手术治疗

获取原文
       

摘要

Background: Successful management of vascular anomaly of head and neck region are often challenging. As the surgical?modality carries high complications and bad aesthetic outcome, the treatment paradigm for these lesions has been?shifting towards the non-invasive one. Because of its high sclerosing effect on vascular endothelium, low cost and easy?availability intralesional Bleomycin injection can be an alternative.Objective: To determine the efficacy and safety of intralesional Bleomycin sclerotherapy for head and neck haemangioma?and slow flow vascular malformation.Methods: Thirty-six patients (12 males and 24 females) with head and neck haemangioma and slow flow vascular?malformations were treated with intralesional Bleomycin injection in the dose of 0.5mg/kg/dose (not exceeding 15 mg/dose) in a medical college of Nepal. The repeat injection was offered every three weeks if needed. The size of the lesion?was measured and serial photographs were taken. Complications were also recorded.Results: Ten patients (28%) had complete resolution (cured), 19 patients (53%) had marked improvement five (14%) had?mild improvement and two (6%) had no response. Minor complications like fever and transient rise in temperature were?seen in eight patients (22%). Hyperpigmentation of the overlying skin were observed in four (11%). None of the patients?developed haematological toxic side effects or pulmonary fibrosis during the follow up.Conclusion: Intralesional Bleomycin injection is simple, safe, effective and non-invasive modality of the treatment for?head and neck haemangioma and slow flow vascular malformation.
机译:背景:成功处理头颈部区域血管异常通常具有挑战性。由于手术方式具有较高的并发症和不良的美学效果,因此这些病变的治疗模式已向非侵入性转移。由于其对血管内皮的高硬化作用,因此成本低廉且容易获得的病灶内注射博来霉素可以作为一种替代选择。在医学院内,对36例头颈部血管瘤和慢流量血管畸形患者(男12例,女24例)进行了病灶内博莱霉素注射液治疗,剂量为0.5mg / kg /剂量(不超过15mg /剂量)尼泊尔如果需要,每三周重复注射一次。测量病变的大小并拍摄系列照片。结果:10例(28%)完全消退(治愈),19例(53%)明显好转5例(14%)轻度改善,2例(6%)无反应。八名患者(22%)出现了诸如发烧和体温短暂升高等轻微并发症。在四个(11%)的皮肤中观察到色素沉着过度。结论:鞘内注射博来霉素是一种简单,安全,有效且无创性的头颈部血管瘤和慢流性血管畸形的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号